Your browser doesn't support javascript.
loading
A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.
Danjou, P; Paty, I; Fruncillo, R; Worthington, P; Unruh, M; Cevallos, W; Martin, P.
Afiliação
  • Danjou P; Wyeth-Ayerst Research, Clinical Pharmacology, Paris, La Defense, France.
Br J Clin Pharmacol ; 48(3): 367-74, 1999 Sep.
Article em En | MEDLINE | ID: mdl-10510148
ABSTRACT

AIMS:

To compare the duration of the residual hypnotic and sedative effects of zaleplon with those of zolpidem and placebo following nocturnal administration at various times before morning awakening.

METHODS:

Zaleplon 10 mg, zolpidem 10 mg, or placebo was administered double-blind to 36 healthy subjects under standardized conditions in a six-period, incomplete-block, crossover study. Subjects were gently awakened and given medication at predetermined times 5, 4, 3, or 2 h before morning awakening, which occurred 8 h after bedtime. When the subjects awoke in the morning, a battery of subjective and objective assessments of residual effects of hypnotics was administered.

RESULTS:

No residual effects were demonstrated after zaleplon 10 mg, when administered as little as 2 h before waking, on either subjective or objective assessments, whereas zolpidem 10 mg showed significant residual effects on DSST and memory (immediate and delayed free recall) after administration up to 5 h before waking and choice reaction time, critical flicker fusion threshold and Sternberg memory scanning after administration up to 4 h before waking. Residual effects of zolpidem were apparent in all objective and subjective measurements when the drug was administered later in the night.

CONCLUSIONS:

The present results demonstrate that zaleplon at the dose of 10 mg is free of residual hypnotic or sedative effects when administered nocturnally as little as 2 h before waking in normal subjects. In contrast, residual effects of zolpidem are still apparent on objective assessments up to 5 h after nocturnal administration, longer than has been reported from studies involving daytime administration.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Pirimidinas / Hipnóticos e Sedativos / Acetamidas Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 1999 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Pirimidinas / Hipnóticos e Sedativos / Acetamidas Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 1999 Tipo de documento: Article País de afiliação: França